AI
AI is an intervention with 26 clinical trials. Currently 8 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
8
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
System-integrated Point-of-Care Ultrasound in Breast Cancer Screening
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
Clinical Trials (26)
Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
System-integrated Point-of-Care Ultrasound in Breast Cancer Screening
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.
Accuracy of Artificial Intelligence Technology in Detecting Number of Root Canal of Human Mandibular Second Molar: Diagnostic Accuracy Experimental Study
Investigation of Impact of AI on Prostate Cancer Workflow
Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis
The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening
Radiomics Model for Assessing Lymph Node Status in cN0 Patients withHNSCC
AI in Respiratory Disease Prevention, Diagnosis, and Triage
Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma
Trial of Artificial Intelligence for Chest Radiography
Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter Study
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 26